ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,814.40
-0.85%
S&P ASX All Technology
3,045.20
-2.07%
Brent Oil
83.76
0.00%
US Dollar vs AUD
1.49165
-0.03%
Bitcoin
67,021.16
-0.09%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Novavax Inc (NVAX)

  7. Novavax Inc (NVAX) News

NVAX

Novavax (NVAX)

Novavax Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NVAX
DateTimeSourceHeadlineSymbolCompany
16/05/202411:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
15/05/202407:02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NVAXNovavax Inc
14/05/202406:10Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:NVAXNovavax Inc
14/05/202406:02PR Newswire (US)Novavax to Participate in BofA Securities 2024 Health Care ConferenceNASDAQ:NVAXNovavax Inc
14/05/202404:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
10/05/202422:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
10/05/202422:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVAXNovavax Inc
10/05/202422:02IH Market NewsNovavax Surges 57% Post $1.4 Billion Sanofi Deal; Apple Boosts Data Centers with AI and Internal Chips, and More NewsNASDAQ:NVAXNovavax Inc
10/05/202416:15PR Newswire (US)Novavax Reports First Quarter 2024 Financial Results and Operational HighlightsNASDAQ:NVAXNovavax Inc
10/05/202416:00PR Newswire (US)Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination VaccinesNASDAQ:NVAXNovavax Inc
09/05/202406:53Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:NVAXNovavax Inc
08/05/202407:21Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:NVAXNovavax Inc
08/05/202404:43Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NVAXNovavax Inc
07/05/202423:25PR Newswire (US)Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational Highlights on May 10, 2024NASDAQ:NVAXNovavax Inc
07/05/202421:44IH Market NewsTesla’s April Sales Down 18% in China, Amazon’s Multi-Billion Dollar Cloud Expansion in Singapore, and More NewsNASDAQ:NVAXNovavax Inc
07/05/202406:43Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:NVAXNovavax Inc
06/05/202420:22GlobeNewswire Inc.Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual MeetingNASDAQ:NVAXNovavax Inc
15/04/202420:00GlobeNewswire Inc.Shah Capital nominates two highly qualified independent director candidates for NovavaxNASDAQ:NVAXNovavax Inc
01/04/202423:00PR Newswire (US)Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024NASDAQ:NVAXNovavax Inc
06/03/202411:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
01/03/202408:02PR Newswire (US)Novavax to Participate in TD Cowen's 44th Annual Health Care ConferenceNASDAQ:NVAXNovavax Inc
29/02/202400:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
29/02/202400:00PR Newswire (US)Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational HighlightsNASDAQ:NVAXNovavax Inc
28/02/202423:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NVAXNovavax Inc
24/02/202400:03IH Market NewsGoldman Sachs Reconsiders Fed Cuts, LUNR Surges Over 40% in Pre-Market, and MoreNASDAQ:NVAXNovavax Inc
22/02/202422:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
22/02/202422:00PR Newswire (US)Novavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase AgreementNASDAQ:NVAXNovavax Inc
21/02/202401:25PR Newswire (US)Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024NASDAQ:NVAXNovavax Inc
01/02/202400:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
26/01/202409:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
 Showing the most relevant articles for your search:NASDAQ:NVAX

Your Recent History

COIN
FANETH
Fanfare Global Token
EU
FGIND
EN Top 30 France Germany...
BIT
UC8ALB
Unicredit Bank
BSTP
STORJUSD
Storj
UPBT
BCHABTC
LATK
FINUSDT
FINTOR
ASX
MRL
Mayur Resources
LATK
CBTUSDT
Community Business Token
COIN
APEIRUSD
UNSW3
CSXETH
Coinstox Token
BIT
F19750
Vontobel Financial Produ...
TSXV
CIP.H
Canadian International P...
BIT
UC3JRS
Unicredit Bank
NASDAQ
SANBW
Sanaby Health Acquisitio...
USOTC
CCOJF
Coca Cola Bottlers Japan (PK)
EU
0473T
0473T
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved